Watch Video Click on the video banner above to watch CEO Carlo Montagner discuss STA’s 2020 Employer of Choice award on Ticker News. For more information visit https://employerofchoiceawards.com.au/eoc-winners-2020/specialised-therapeutics-2020-eoc/
![Arctica Specialised Therapeutics](https://stabiopharma.com/wp-content/uploads/2021/03/stabio-logo.png)
+65 3158 9940
1300 798 820
+64 9801 0299
Watch Video Click on the video banner above to watch CEO Carlo Montagner discuss STA’s 2020 Employer of Choice award on Ticker News. For more information visit https://employerofchoiceawards.com.au/eoc-winners-2020/specialised-therapeutics-2020-eoc/
PHARMADISPATCH 6 November 2020 Australians Will Need to ‘Reconcile Themselves to this New Reality’ November 6, 2020 — Privately owned Australian pharmaceutical company Specialised Therapeutics Asia has signed an exclusive distribution agreement for a new therapy to treat advanced gastrointestinal stromal tumours (GIST). The agreement with US-based Deciphera Pharmaceuticals covers the commercialisation of switch-control tyrosine kinase
Singapore, 06 November 2020: A NEW therapy to treat advanced gastrointestinal stromal tumours (GIST) will be available to patients in Australia, New Zealand and in some parts of South East Asia, following an exclusive distribution agreement. Independent pharmaceutical company Specialised Therapeutics Asia (STA) has signed an agreement with US-based Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) to commercialise the
PHARMADISPATCH 6 November 2020 Australian Company Adds to its Oncology Portfolio with GIST Therapy November 6, 2020 — Privately owned Australian pharmaceutical company Specialised Therapeutics Asia has signed an exclusive distribution agreement for a new therapy to treat advanced gastrointestinal stromal tumours (GIST). The agreement with US-based Deciphera Pharmaceuticals covers the commercialisation of switch-control
LIVING WITH SMALL CELL LUNG CANCER: MEET FRASER STEWART New lung cancer therapies bring hope to people like Fraser Stewart. The 64-year-old father of two and retired diesel mechanic was diagnosed with Small Cell Lung Cancer in July 2019. Already he has endured rounds of chemotherapy, radiotherapy and immunotherapy. Now he hopes another
73 year-old Brian Flynn loves a beer, his family and the St Kilda Football Club. The former industrial cleaner was close to retirement when first diagnosed with lung cancer five years ago. He had been a heavy smoker as a younger man, and was originally diagnosed after doctors investigated the source of his chest pain.
The following article features in Issue One of the ST BREAST magazine. Vanessa was 43 years old and a single mum to two children aged five and three when she was diagnosed with breast cancer in 2016. She had a mortgage and took eight months off work, using all her accrued annual leave and sick
Dale Ischia is an accredited exercise physiologist and a cancer exercise specialist. She says it’s now “beyond doubt” that exercise is vital before, during and after a breast cancer diagnosis, with the benefits not only physical.
The following article features in Issue One of the ST BREAST magazine. Heather Plaister clearly remembers the moment she found a breast lump. A woman of great faith, she had said a morning prayer before asking God if there was someone she should be praying for. “Then it was just like a thought process
Melbourne, Australia, 8 October 2020: Independent pharmaceutical company Specialised Therapeutics Australia (STA) has been recognised as an Employer of Choice in The Australian Business Awards 2020. The prestigious awards recognize organisations demonstrating business innovation, product innovation, technological achievement and employee engagement via a set of comprehensive award categories. The Employer of Choice (EOC) accolade in particular,